TCT Saglik – Transforming Future of Medicine
Türkiye Cell Therapies
At TCT Saglik, we are pioneering next-generation cell and gene therapies to revolutionize the future of medicine. We aim to bring biotechnology solutions to Türkiye through technology transfer, strategic collaborations, licensing aggrements and local innovation.
We specialize in CAR-T therapy, cell-based treatments, and advanced biopharmaceutical solutions, working alongside global industry leaders like AbClon and Cytiva to accelerate the development, licensing and commercialization of innovative treatments.
Through our commitment to R&D, clinical advancements, and high-quality manufacturing, we aim to establish Türkiye as a key biotechnology hub, ensuring that transformative treatments reach patients faster and more efficiently.
Join us as we push the boundaries of science, create breakthrough therapies, and shape the future of personalized medicine.
TCT Saglik
Advancing Science, Delivering Hope.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Istanbul, Ümraniye 34774, Tr
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.tctsaglik.com
- Keywords
- health, cellandgenetherapies, treatments.
- HQ
- Istanbul, Ümraniye
Tct Saglik Questions
Tct Saglik's website is http://www.tctsaglik.com
Tct Saglik's LinkedIn profile is https://tr.linkedin.com/company/tct-saglik
Tct Saglik has
1 employees.
View email and phone details for 1
employees at Tct Saglik.
Tct Saglik's industry is
Biotechnology Research
Tct Saglik's top competitors are
Trustlife Labs Drug R&d Center,
Meta Analitik Çözümler,
Bloocell®,
Heka,
Health Institutes Of Türkiye,
Ant Teknik,
Szaomics,
Abclon,
Peptron, Inc.,
Trustlife Ventures.
Tct Saglik's categories are Biotechnology Research
Tct Saglik's founding year is 2024
